What this toolkit is for, and who should use it
Patent prosecution is the multi-year process of obtaining a patent from the United States Patent and Trademark Office (USPTO): capturing an invention, searching the prior art, drafting an application, filing it, negotiating with an examiner, and — if successful — securing an issued patent and keeping it alive. It is part technical writing, part advocacy, and part procedure, and a single misstep early on can be impossible to fix later. This toolkit maps the whole journey so an inventor, a startup founder, an in-house counsel, or a litigator who needs to understand how a patent was built can navigate the field and find the right deep-dive resource at each step.
A word of orientation. Patent prosecution is highly specialized and is generally practiced by registered patent attorneys and patent agents who have passed the USPTO registration exam. This toolkit will help you understand and manage the process and prepare effectively, but most inventors should engage a registered practitioner, especially for claim drafting and office-action responses where the stakes are highest. For the conceptual foundation, start with Patent Basics — A Plain-English Guide and General Information Concerning Patents.
Roadmap at a glance
- Invention capture — documenting the invention through a disclosure.
- Patentability and freedom-to-operate (FTO) searching — what's already out there, and can you practice your invention.
- Provisional vs. nonprovisional — choosing the filing vehicle and priority strategy.
- Drafting — the specification and the claims, the heart of the patent.
- Filing — submitting through Patent Center and assembling the application.
- Examination and office actions — the back-and-forth with the examiner.
- Obviousness and eligibility — the two rejections that decide most cases.
- Allowance and issuance — closing the prosecution and getting the grant.
- Maintenance — paying fees to keep the patent in force.
- Duty of candor — the obligation that runs through every stage.
Two authorities span the entire process: the Manual of Patent Examining Procedure (MPEP) — the examiner's playbook, free at uspto.gov/web/offices/pac/mpep — and Title 35 of the U.S. Code together with the patent rules in 37 C.F.R. Part 1. Filing and case management happen in Patent Center at patentcenter.uspto.gov. The companion full-length overview is Utility Patent Basics and Patent Basics and General Information Concerning Patents.
Stage 1 — Invention capture (the disclosure)
Prosecution begins long before any filing, with a thorough invention disclosure — the inventor's written description of what was invented, how it works, what problem it solves, and how it differs from what came before. A good disclosure is the raw material from which a patent attorney drafts; a thin one produces a thin application. Capture the conception date, the inventors (inventorship is a legal question with real consequences, not a courtesy), any public disclosures or sales (which start statutory clocks), and the closest known prior art.
Beware the timing traps. Under the America Invents Act, the U.S. is a first-inventor-to-file system, so delay can let someone else win the race. And 35 U.S.C. § 102(b)(1) gives only a one-year grace period from the inventor's own public disclosure or offer for sale before that disclosure becomes barring prior art — and many foreign jurisdictions give no grace period at all, so any public disclosure can forfeit foreign rights. File before you publish, pitch, or sell where possible.
Prepare the disclosure with the Preparing an Invention Disclosure Checklist and the explanatory How to Prepare an Invention Disclosure for Your Patent Attorney. Where employees invent, confirm ownership through assignment agreements — see Employee Invention Assignment Agreements.
Resources
- Checklists: Preparing an Invention Disclosure Checklist
- Articles: How to Prepare an Invention Disclosure for Your Patent Attorney; Patent Basics — A Plain-English Guide; Employee Invention Assignment Agreements
- Primary authority: 35 U.S.C. § 100 (definitions); § 102 (novelty and the one-year grace period); § 116 (joint inventors); § 118 (filing by assignee).
- External: USPTO inventor resources; MPEP ch. 2100.
Stage 2 — Patentability and freedom-to-operate searching
Two different searches serve two different purposes, and they are often confused. A patentability (prior-art) search asks: is my invention new and non-obvious enough to be patented? A freedom-to-operate (FTO) search asks the opposite question: can I make, use, or sell my product without infringing someone else's in-force patent? You can have a perfectly patentable invention that still infringes a broader existing patent — patentability and FTO are independent.
Do the patentability search first to decide whether to invest in an application and to anticipate the examiner's best prior art. Do the FTO analysis before you launch a product, because an injunction can shut down a business. The FTO methodology is laid out in Conducting Freedom-to-Operate Analysis for New Products and worked through in the Freedom to Operate Search Checklist; the broader clearance picture is the Freedom to Operate and IP Clearance Toolkit.
Resources
- Checklists: Freedom to Operate Search Checklist
- Articles: Conducting Freedom-to-Operate Analysis for New Products
- Primary authority: 35 U.S.C. § 102 (novelty); § 103 (non-obviousness); § 271 (infringement — relevant to FTO).
- External: USPTO Patent Public Search; Google Patents; Espacenet (EPO); MPEP § 904 (search).
Stage 3 — Provisional vs. nonprovisional
The first filing decision is whether to file a provisional or a nonprovisional application. A provisional application (35 U.S.C. § 111(b)) is a lower-cost placeholder that secures a priority date for 12 months, is never examined, and never issues — you must file a corresponding nonprovisional within the year to claim its benefit. It is valuable for buying time, establishing priority before a disclosure, and deferring cost. But it only confers priority for subject matter it actually describes in adequate detail under § 112; a sloppy "provisional" can give a false sense of security.
A nonprovisional application (35 U.S.C. § 111(a)) is the real thing — it is examined and can mature into an issued patent. Many applicants file a provisional first, then a nonprovisional within 12 months, then pursue foreign filings under the Patent Cooperation Treaty (PCT) within the same priority year. Decide the path with the broader Utility Patent Basics, and if the invention is about how a product looks rather than how it works, run the design-vs-utility analysis in the Choosing Between a Design and Utility Patent Checklist and the Design Patent Toolkit.
Resources
- Checklists: Choosing Between a Design and Utility Patent Checklist
- Articles: Utility Patent Basics; General Information Concerning Patents; Design Patents v. Utility Patents — Key Differences
- Primary authority: 35 U.S.C. § 111(a)–(b) (applications); § 119 (priority); § 120 (benefit of earlier filing); § 171 (design patents).
- External: USPTO provisional application guide; WIPO PCT; MPEP ch. 200, 600.
Stage 4 — Drafting the specification and claims
Drafting is the craft at the center of prosecution. The specification must satisfy 35 U.S.C. § 112: it must describe the invention in enough detail that a person of ordinary skill could make and use it (enablement and written description), and the claims must particularly point out and distinctly claim the invention (definiteness). The Supreme Court's Nautilus, Inc. v. Biosig Instruments, Inc., 572 U.S. 898 (2014), set the definiteness standard — claims that fail to inform skilled artisans of the scope with "reasonable certainty" are invalid — and Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), tightened enablement for broad functional claims.
The claims define the legal scope of the monopoly; everything in the specification supports them. Independent claims set the broadest protection; dependent claims add fallback positions. Claim drafting is where most of a patent's eventual value (and most of its vulnerability) is set, which is why this stage above all rewards an experienced practitioner. The strategic backdrop — how claims drive both prosecution and later litigation — is developed in What Constitutes Patent Infringement: Claims and Defenses.
Resources
- Articles: Utility Patent Basics; What Constitutes Patent Infringement: Claims and Defenses; Patent Basics — A Plain-English Guide
- Primary authority: 35 U.S.C. § 112(a) (written description and enablement); § 112(b) (definiteness); § 112(f) (means-plus-function); Nautilus v. Biosig, 572 U.S. 898 (2014); Amgen v. Sanofi, 598 U.S. 594 (2023).
- External: MPEP ch. 2100, 2160–2190 (§ 112 issues); USPTO claim drafting resources.
Stage 5 — Filing
Applications are filed electronically through Patent Center, the USPTO's unified filing and management system (which replaced the legacy EFS-Web and PAIR). A complete utility nonprovisional filing includes the specification, claims, drawings (where necessary to understand the invention), an oath or declaration by the inventors, an application data sheet, and the filing/search/examination fees. Many applicants qualify for reduced fees as a small entity or micro entity — confirm eligibility, because falsely claiming reduced-fee status can have consequences. Fees change; verify current amounts on the USPTO fee schedule before filing.
At or shortly after filing, you will also begin satisfying the duty of candor by preparing an Information Disclosure Statement (IDS) listing material prior art (see Stage 10). For the end-to-end mechanics, General Information Concerning Patents and Patent Basics and General Information Concerning Patents walk through the components.
Resources
- Articles: General Information Concerning Patents; Patent Basics and General Information Concerning Patents
- Primary authority: 35 U.S.C. § 111 (filing); § 115 (inventor's oath/declaration); 37 C.F.R. § 1.51, 1.53, 1.76 (application components); 37 C.F.R. § 1.27–1.29 (small/micro entity).
- External: USPTO Patent Center; USPTO fee schedule (verify current amounts); MPEP ch. 500, 600.
Stage 6 — Examination and office actions
After filing, the application waits in queue and is then assigned to an examiner who searches the prior art and issues an office action — usually a rejection of some or all claims under §§ 101, 102, 103, and/or 112. This is normal: most applications receive at least one rejection. You respond with arguments (traversing the rejection), claim amendments, or both. A first office action is typically non-final; a second is often final, after which your options narrow to an after-final response, a Request for Continued Examination (RCE), or an appeal to the Patent Trial and Appeal Board (PTAB).
Responding well is the core advocacy skill of prosecution: identify exactly what the examiner found, distinguish the references or amend around them without surrendering more scope than necessary, and watch prosecution history estoppel — every argument and amendment can be used against you later in litigation. The strategies are detailed in Responding to Patent Office Actions — Strategies for Overcoming Rejections and the Responding to a Patent Office Action Checklist.
Resources
- Checklists: Responding to a Patent Office Action Checklist
- Articles: Responding to Patent Office Actions — Strategies for Overcoming Rejections
- Primary authority: 35 U.S.C. § 132 (notice of rejection); § 134 (appeal to PTAB); 37 C.F.R. § 1.111, 1.114 (replies; RCE).
- External: MPEP ch. 700 (examination), 1200 (appeal); PTAB.
Stage 7 — Obviousness and eligibility: the two decisive rejections
Two rejections decide the outcome of most applications and deserve their own stage.
Obviousness (§ 103). A claim is unpatentable if the differences between it and the prior art would have been obvious to a person of ordinary skill at the time. The governing framework comes from Graham v. John Deere Co., 383 U.S. 1 (1966), and was reshaped by KSR International Co. v. Teleflex Inc., 550 U.S. 398 (2007), which rejected a rigid "teaching-suggestion-motivation" test in favor of a flexible, common-sense inquiry — making obviousness rejections easier for examiners to assert and harder to overcome. Effective rebuttals attack the motivation to combine, argue teaching away, or marshal objective indicia (commercial success, long-felt need, unexpected results). Work through them with Overcoming Obviousness Rejections — A Comprehensive Guide to Section 103 Analysis and the Overcoming an Obviousness Rejection Checklist.
Subject-matter eligibility (§ 101). Some inventions — abstract ideas, laws of nature, natural phenomena — are not eligible no matter how novel. The two-step Alice/Mayo framework from Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014), asks (1) whether the claim is directed to an ineligible concept and, if so, (2) whether it adds an "inventive concept" that transforms it into a patent-eligible application. Software and business-method claims live or die here. The doctrine is notoriously unsettled, and Congress and the courts continue to debate reform. Strategy is in Patent Eligibility After Alice and the Patent Subject Matter Eligibility (Alice) Checklist.
Resources
- Checklists: Overcoming an Obviousness Rejection Checklist; Patent Subject Matter Eligibility (Alice) Checklist
- Articles: Overcoming Obviousness Rejections (Section 103); Patent Eligibility After Alice
- Primary authority: 35 U.S.C. § 101 (eligibility); § 103 (obviousness); Graham v. John Deere, 383 U.S. 1 (1966); KSR v. Teleflex, 550 U.S. 398 (2007); Alice v. CLS Bank, 573 U.S. 208 (2014); Mayo v. Prometheus, 566 U.S. 66 (2012).
- External: MPEP § 2106 (eligibility), § 2141–2145 (obviousness); USPTO patent eligibility guidance.
Stage 8 — Allowance and issuance
When the examiner is satisfied, you receive a Notice of Allowance and pay the issue fee within the statutory window. Before issuance, do a final review: confirm the allowed claims read on your commercial product, consider whether to file a continuation to keep prosecution alive for additional or broader claims (you cannot do this after the parent issues unless a child is already pending), and check the drawings and data. After the issue fee posts, the patent grants and the term clock — generally 20 years from the earliest non-provisional U.S. filing date (35 U.S.C. § 154), subject to patent term adjustment for USPTO delay — governs.
Issuance also triggers practical duties. Mark products to preserve damages — see Patent Marking Compliance Checklist and Understanding Patent Marking Requirements — and consider licensing the issued patent, covered in How to License Your Patent: From Valuation to Term Sheet and the Patent License Term Sheet Checklist.
Resources
- Checklists: Patent Marking Compliance Checklist; Patent License Term Sheet Checklist
- Articles: Understanding Patent Marking Requirements; How to License Your Patent: From Valuation to Term Sheet
- Primary authority: 35 U.S.C. § 151 (issue of patent); § 154 (term); § 287 (marking); 37 C.F.R. § 1.311, 1.53(b) (continuations).
- External: MPEP ch. 1300; USPTO patent term and adjustment.
Stage 9 — Maintenance fees
A U.S. utility patent is not "set and forget." Maintenance fees are due at 3.5, 7.5, and 11.5 years after issuance (35 U.S.C. § 41; 37 C.F.R. § 1.20, 1.362), and if you miss them, the patent expires. There is a six-month grace period with a surcharge, and a limited path to reinstatement for unintentional lapses, but the safest course is to docket the deadlines rigorously. Maintenance fees rise at each stage, an intentional design that prompts owners to abandon patents they no longer value. Design patents, by contrast, carry no maintenance fees. Verify all current amounts and dates on the USPTO fee schedule.
Resources
- Articles: General Information Concerning Patents; Utility Patent Basics
- Primary authority: 35 U.S.C. § 41(b) (maintenance fees); 37 C.F.R. § 1.362–1.378 (payment and reinstatement).
- External: USPTO maintenance fee schedule and payment (verify current amounts/deadlines); MPEP ch. 2500.
Stage 10 — Duty of candor (runs throughout)
The duty of candor and good faith under 37 C.F.R. § 1.56 is not a stage so much as an obligation that attaches to everyone substantively involved in prosecuting an application, from filing through issuance. It requires disclosing to the USPTO all information known to be material to patentability — chiefly through Information Disclosure Statements. Breach the duty with intent to deceive and you risk inequitable conduct, which the Federal Circuit calls the "atomic bomb" of patent law because it can render the entire patent (and sometimes related patents) unenforceable.
The modern standard from Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276 (Fed. Cir. 2011) (en banc), requires proving both but-for materiality and specific intent to deceive — a deliberately high bar — but the consequences are catastrophic, so prosecute cleanly. The doctrine is covered in Inequitable Conduct in Patent Prosecution — Navigating the Atomic Bomb of Patent Law and operationalized in the Maintaining the Duty of Candor to Avoid Inequitable Conduct Checklist. The litigation flip side — how an accused infringer hunts for inequitable conduct — is in Finding Evidence of Inequitable Conduct in Patent Prosecution.
Resources
- Checklists: Maintaining the Duty of Candor to Avoid Inequitable Conduct Checklist
- Articles: Inequitable Conduct in Patent Prosecution; Finding Evidence of Inequitable Conduct in Patent Prosecution
- Primary authority: 37 C.F.R. § 1.56 (duty of disclosure); § 1.97–1.98 (IDS); Therasense v. Becton, Dickinson, 649 F.3d 1276 (Fed. Cir. 2011).
- External: MPEP ch. 2000 (duty of disclosure).
Putting it together: a worked illustration
Illustration (hypothetical). A startup invents a sensor-fusion algorithm. The team prepares a detailed disclosure and confirms inventorship and assignment (Stage 1). A patentability search shows the core idea is novel; an FTO search flags a broad third-party patent to design around (Stage 2). To preserve a priority date before a trade-show demo, they file a robust provisional, then a nonprovisional and a PCT within 12 months (Stage 3). Counsel drafts claims with strong § 112 support and fallback dependent claims (Stage 4) and files through Patent Center with an IDS (Stage 5). The first office action rejects the claims under §§ 103 and 101; the team distinguishes the prior art and amends to recite a concrete technical improvement, overcoming both KSR and Alice hurdles (Stages 6–7). A Notice of Allowance issues; they file a continuation to keep prosecution open and mark products (Stage 8), docket the 3.5/7.5/11.5-year maintenance fees (Stage 9), and maintain a clean IDS record throughout to avoid inequitable-conduct exposure (Stage 10). That is the toolkit from idea to issued, maintained patent.
Master resource index
Articles
- Patent Basics — A Plain-English Guide
- General Information Concerning Patents
- Patent Basics and General Information Concerning Patents
- Utility Patent Basics
- How to Prepare an Invention Disclosure for Your Patent Attorney
- Conducting Freedom-to-Operate Analysis for New Products
- Responding to Patent Office Actions — Strategies for Overcoming Rejections
- Overcoming Obviousness Rejections (Section 103)
- Patent Eligibility After Alice
- Inequitable Conduct in Patent Prosecution
- Finding Evidence of Inequitable Conduct in Patent Prosecution
- Understanding Patent Marking Requirements
- How to License Your Patent: From Valuation to Term Sheet
- Employee Invention Assignment Agreements
- What Constitutes Patent Infringement: Claims and Defenses
- Design Patents v. Utility Patents — Key Differences
Checklists
- Preparing an Invention Disclosure Checklist
- Freedom to Operate Search Checklist
- Responding to a Patent Office Action Checklist
- Overcoming an Obviousness Rejection Checklist
- Patent Subject Matter Eligibility (Alice) Checklist
- Choosing Between a Design and Utility Patent Checklist
- Patent Marking Compliance Checklist
- Maintaining the Duty of Candor to Avoid Inequitable Conduct Checklist
- Patent License Term Sheet Checklist
Related toolkits
External & primary sources
- USPTO — uspto.gov/patents
- Patent Center (filing/management) — patentcenter.uspto.gov
- Manual of Patent Examining Procedure (MPEP) — uspto.gov/web/offices/pac/mpep
- Patent Public Search — ppubs.uspto.gov
- Fee schedule (verify current amounts) — uspto.gov/learning-and-resources/fees-and-payment
- Key statutes/rules: 35 U.S.C. §§ 101, 102, 103, 111, 112, 115, 119, 120, 132, 134, 151, 154, 171, 287, 41; 37 C.F.R. §§ 1.56, 1.97–1.98, 1.111, 1.114
- Key cases: KSR v. Teleflex, 550 U.S. 398 (2007); Alice v. CLS Bank, 573 U.S. 208 (2014); Mayo v. Prometheus, 566 U.S. 66 (2012); Graham v. John Deere, 383 U.S. 1 (1966); Nautilus v. Biosig, 572 U.S. 898 (2014); Amgen v. Sanofi, 598 U.S. 594 (2023); Therasense v. Becton, Dickinson, 649 F.3d 1276 (Fed. Cir. 2011)
This toolkit is general legal information, not legal advice, and does not create an attorney-client relationship. Patent prosecution is highly specialized; USPTO fees, rules, and eligibility law change frequently. Verify current requirements at uspto.gov and consult a registered patent attorney or agent for your specific matter.